STOCKHOLM, Sept. 20, 2022 /PRNewswire/ Updated 12-month results from the open-label investigator-initated Phase II clinical trial GADinLADA that assessed three intralymphatic injections of
STOCKHOLM, July 7, 2022 /PRNewswire/ The primary endpoints of safety and tolerability were met in the open-label investigator-initiated Phase II clinical trial GADinLADA, in which the diabetes
/PRNewswire/ The primary endpoints of safety and tolerability were met in the open-label investigator-initiated Phase II clinical trial GADinLADA, in which.
Diamyd Medical AB: First patient enrolled in Diamyd Medical s Phase III trial DIAGNODE-3 privataaffarer.se - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from privataaffarer.se Daily Mail and Mail on Sunday newspapers.
STOCKHOLM, April 20, 2022 /PRNewswire/ An update of a large-scale meta-analysis supporting the efficacy of the therapeutic diabetes vaccine Diamyd in individuals recently diagnosed with Type